Quality assurance of CFU-GM assays: Inter-laboratory variation despite standard reagents

European Journal of Haematology

Volumn 62, Issue 1, 1999, Pages 32-37

  Lumley, M A ^a,d   Burton, A ^b   Billingham, L J ^b   McDonald, D F ^c   Czarnecka, H M ^c   Milligan, D W ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Regional Blood Transfusion Service   (United Kingdom)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

CFU GM; Clonogenic assay; Commercial kit; PBPC; Quality assurance

Indexed keywords

MONOCLONAL ANTIBODY; REAGENT;

ANTIGEN EXPRESSION; ARTICLE; CLONOGENIC ASSAY; COLONY FORMING UNIT GM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LABORATORY TEST; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; STEM CELL;

EID: 0032909694     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1999.tb01111.x     Document Type: Article

References (21)

1. BENDER JG, BIK TO L, WILLIAMS S, SCHWARTZBERG LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992;1:329-341.
2. WUNDER E, SOVALAT H, FRITSCH G, SILVESTRI F, HENON P, SERKE S. Report on the European workshop on peripheral blood stem cell determination and standardization - Mulhouse, France, February 6-8 and 14-15, 1992. J Hematother 1992;1:131-142.
3. SOVALAT H, WUNDER E, TIENHAARA A, et al. Commentary: prospects for standardization of stem cell determination within Europe. J Hematother 1993;3:293-296.
4. TO LB, ROBERTS MM, RAWLING CM, et al. Establishment of a clinical threshold cell dose: correlation between CFU-GM and duration of aplasia In: WUNDER E, SOVALAT H, HENON PR, SERKE, S, eds. Hematopoietic stem cells, the Mulhouse manual. Dayton, OH: AlphaMed Press, 1994:15-20.
5. HUTCHINSON RM, BELL AJ, DUGUID KM, et al. Guidelines for the collection, processing and storage of human bone marrow and peripheral stem cells for transplantation. BCSH Blood Transfusion Task Force. Transfus Med 1994;4:165-172.
6. SIENA S, BREGNI M, BRANDO B, et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 1991;77:400-409.
7. HAAS R, MOHLE R, FRUHAUF S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83:3787-3794.
8. + cell fraction in bone marrow and blood is not universally predictive of CFU-GM. Exp Hematol 1992;20:528-530.
9. BARRETT AJ, FAILLE A, KETELS F. Variations in granulocyte colony forming cell numbers in adult blood. Br J Haematol 1979;42:337-344.
10. MESSNER HA. Human stem cells in culture In: MCCULLOCH EA, ed. Cell culture techniques. Clinics in Haematology 1984;13:393-404.
11. LEWIS LD, RAWLING T, DYSON PG, HAYLOCK DN, JUTTNER CA, TO LB. Standardisation of the CFU-GM assay using hematopoietic growth factors. J Hematother 1996;5:625-630.
12. MCDONALD DF, CZARNECKA HM, LUMLEY MA, LAWLEY A. An investigation of the source of discrepancy in the results of CFU-GM assays. Transfus Med 1995;5(suppl 1):45(abstr).
13. LUMLEY MA, BURGESS R, BILLINGHAM LJ, MCDONALD DF, MILLIGAN DW. Colony counting is a major source of variation in CFU-GM results between centres. Br J Haematol 1997;97:481-484.
14. LOKEN MR, CIVIN CI. Laboratory assessment of lympho-hematopoietic progenitor and stem cells In: SMITH DM, SACHER RA, eds. Peripheral blood stem cells. Bethesda, MD: American Association of Blood Banks, 1993:19-31.
15. SERKE S, ARSENIEV L, WATTS M, et al. Imprecision of counting CFU-GM colonies and CD34-expressing cells. Bone Marrow Transpl 1997;20:57-61.
16. TO LB. Assaying the CFU-GM in blood: correlation between cell dose and haemopoietic reconstitution. Bone Marrow Transpl 1990;5(suppl 1):16-18.
17. TO LB, HAYLOCK DN, JUTTNER CA, KIMBER J. The effect of monocytes in the peripheral blood CFU-C assay system. Blood 1983;62:112-117.
18. LACKEY DA, HILLYER CD. Colony-forming unit culture of bone marrow and peripheral blood stem cells: comparison of commercially available media. J Hematother 1992;1:289-292.
19. SMITH NA, CZARNECKA HM, LAWLEY AJ, LUMLEY MA, MELLOR P, MCDONALD DF. Comparison of commercial and in-house CFU-GM assays and relationships with CD34 assays in PBPC collections. Transfus Med 1996;6(suppl 2):34(abstr).
20. CIRENZA E. Peripheral blood progenitor cells: mobilization and transplantation In: SMITH DM, SACHER RA, eds. Peripheral blood stem cells. Bethesda, MD: American Association of Blood Banks, 1993:45-63.
21. + cell estimation in leucapheresis products. Bone Marrow Transpl 1996;18:791-796.